Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Apexigen, a California antibody company with strong...
3SBio acquired China rights for a novel...
JHL Biotech, a Taiwan-China biopharma that develops...
Sino Biopharma plans to invest up to $129 million in...
Baiyunshan Pharma will raise $1.6 billion in a secondary...
MicroConstants China in-licensed global rights to novel...
Last week, Regenerx was awarded a patent in China for its...
China's economy made an indelible impression on the world...
The ChinaBio® Stock Index, comprised of 17...
Ascenta Therapeutics of the US has struck a deal to...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
